{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T02:27:19Z","timestamp":1745375239984},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,10,2]],"date-time":"2012-10-02T00:00:00Z","timestamp":1349136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s12094-012-0941-9","type":"journal-article","created":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T13:29:23Z","timestamp":1349098163000},"page":"398-402","source":"Crossref","is-referenced-by-count":15,"title":["Circulating autoantibody to ABCC3 may be a potential biomarker for esophageal squamous cell carcinoma"],"prefix":"10.1007","volume":"15","author":[{"given":"Y.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,2]]},"reference":[{"key":"941_CR1","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMra035010","volume":"349","author":"PC Enzinger","year":"2003","unstructured":"Enzinger PC, Mayer RJ (2003) Esophagealcancer. N Engl J Med 349:2241\u20132245","journal-title":"N Engl J Med"},{"key":"941_CR2","first-page":"459","volume":"110","author":"KY Lam","year":"1997","unstructured":"Lam KY, Ma L (1997) Pathology of esophageal cancers: local experience and current insights. Chin Med J (Eng) 110:459\u2013464","journal-title":"Chin Med J (Eng)"},{"key":"941_CR3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.11029","volume":"105","author":"AP Polednak","year":"2003","unstructured":"Polednak AP (2003) Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer 105:98\u2013100","journal-title":"Int J Cancer"},{"key":"941_CR4","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/annonc\/mdm007","volume":"18","author":"C Chapman","year":"2007","unstructured":"Chapman C, Murray A, Chakrabarti J, Thorpe A, Woolston C, Sahin U, Barnes A, Robertson J (2007) Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol 18:868\u2013873","journal-title":"Ann Oncol"},{"key":"941_CR5","doi-asserted-by":"crossref","first-page":"6880","DOI":"10.1111\/j.1742-4658.2009.07396.x","volume":"276","author":"HT Tan","year":"2009","unstructured":"Tan HT, Low J, Lim SG (2009) Serum autoantibodies as biomarkers for early cancer detection. FEBS J 276:6880\u20136904","journal-title":"FEBS J"},{"key":"941_CR6","first-page":"791","volume":"86","author":"R Ranju","year":"2000","unstructured":"Ranju R, Arora S, Chattopadhyay TK, Shukla NK, Mathur M (2000) Circulating p53 antibodies, p53 gene mutational profile and product accumulation in esophageal squamous-cell carcinoma in India. Int J Cancer 86:791\u2013795","journal-title":"Int J Cancer"},{"key":"941_CR7","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/1097-0142(20001015)89:8<1677::AID-CNCR5>3.0.CO;2-9","volume":"89","author":"H Shimada","year":"2000","unstructured":"Shimada H, Takeda A, Arima M, Okazumi S, Matsubara H, Nabeya Y, Funami Y, Hayashi H, Gunji Y, Suzuki T, Kobayashi S, Ochiai T (2000) Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma. Cancer 89:1677\u20131683","journal-title":"Cancer"},{"key":"941_CR8","first-page":"6415","volume":"12","author":"Y Fujita","year":"2006","unstructured":"Fujita Y, Nakanishi T, Hiramatsu M, Mabuchi H, Miyamoto Y, Miyamoto A, Shimizu A, Tanigawa N (2006) Proteomics based approach identifying autoantibody against Peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma. FEBS J 12:6415\u20136420","journal-title":"FEBS J"},{"key":"941_CR9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.canlet.2008.01.013","volume":"263","author":"Y Fujita","year":"2008","unstructured":"Fujita Y, Nakanishi T, Miyamoto Y, Hiramatsu M, Mabuchi H, Miyamoto A, Shimizu A, Takubo T, Tanigawa N (2008) Protemics based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma. Cancer Lett 263:280\u2013290","journal-title":"Cancer Lett"},{"key":"941_CR10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1479-5876-8-81","volume":"8","author":"J Dong","year":"2010","unstructured":"Dong J, Zeng BH, Xu LH, Wang JY, Li MZ, Zeng MS, Liu WL (2010) Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma. J Transl Med 8:81. doi: 10.1186\/1479-5876-8-81","journal-title":"J Transl Med"},{"key":"941_CR11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3748\/wjg.v17.i10.1373","volume":"17","author":"J-H Zhou","year":"2011","unstructured":"Zhou J-H, Zhang B, Kernstine KH, Zhong L (2011) Autoantibodies against MMP-7 as a novel diagnostic biomarker in esophageal squamous cell carcinoma. World J Gastroenterol 17:1373\u20131378","journal-title":"World J Gastroenterol"},{"key":"941_CR12","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.2174\/092986711797189682","volume":"18","author":"L Gatti","year":"2011","unstructured":"Gatti L, Cossa G, Beretta GL, Zaffaroni N, Perego P (2011) Novel insights into targeting ATP-binding cassette transporters for antitumor therapy. Curr Med Chem 18:4237\u20134249","journal-title":"Curr Med Chem"},{"key":"941_CR13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-60761-416-6_5","volume":"596","author":"AM Calcagno","year":"2010","unstructured":"Calcagno AM, Ambudkar SV (2010) Molecular mechanisms of drug resistance in single-step and multi-step drug-selected cancer cells. Methods Mol Biol 596:77\u201393","journal-title":"Methods Mol Biol"},{"key":"941_CR14","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3324\/haematol.2010.031823","volume":"96","author":"C Marzac","year":"2011","unstructured":"Marzac C, Garrido E, Tang R, Fava F, Hirsch P, De Benedictis C, Corre E, Lapusan S, Lallemand JY, Marie JP, Jacquet E, Legrand O (2011) ATP binding cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients. Haematologica 96:1293\u20131301","journal-title":"Haematologica"},{"key":"941_CR15","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/gcc.21967","volume":"51","author":"L Partanen","year":"2012","unstructured":"Partanen L, Staaf J, Tanner M, Tuominen VJ, Borg A, Isola J (2012) Amplification and overexpression of the ABCC3 (MRP3) gene in primary breast cancer. Genes Chromosomes Cancer 51:832\u2013840","journal-title":"Genes Chromosomes Cancer"},{"key":"941_CR16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/1471-2105-11-568","volume":"11","author":"P Wang","year":"2010","unstructured":"Wang P, Sidney J, Kim Y, Sette A, Lund O, Nielsen M, Peters B (2010) Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinforma 11:568. doi: 10.1186\/1471-2105-11-568","journal-title":"BMC Bioinforma"},{"issue":"suppl 2","key":"941_CR17","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1745-7580-6-S2-S7","volume":"6","author":"J S\u00f6llner","year":"2010","unstructured":"S\u00f6llner J, Heinzel A, Summer G, Fechete R, Stipkovits L, Szathmary S, Mayer B (2010) Concept and application of a computational vaccinology workflow. Immunome Res 6(suppl 2):S7","journal-title":"Immunome Res"},{"key":"941_CR18","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s00432-012-1260-9","volume":"138","author":"L Liu","year":"2012","unstructured":"Liu L, Liu N, Liu B, Yang Y, Zhang Q, Zhang W, Yu P, Jin Y, Guo J, Guan S, Sun S, Miao L, Wei J (2012) Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer? J Cancer Res Clin Oncol 138:1737\u20131742","journal-title":"J Cancer Res Clin Oncol"},{"key":"941_CR19","first-page":"875","volume":"19","author":"K Mayerhofer","year":"1999","unstructured":"Mayerhofer K, Tempfer C, Kucera E, Hefler L, Zeisler H, Kainz C, Zeillinger R, Sliutz G (1999) Humoral p53 antibody response is a prognostic parameter in ovarian cancer. Anticancer Res 19:875\u2013878","journal-title":"Anticancer Res"},{"key":"941_CR20","first-page":"569","volume":"20","author":"B Abendstein","year":"2000","unstructured":"Abendstein B, Daxenbichler G, Windbichler G, Zeimet AG, Geurts A, Sweep F, Marth C (2000) Predictive value of uPA, PAI-1, HER-2 and VEGF in the serum of ovarian cancer patients. Anticancer Res 20:569\u2013572","journal-title":"Anticancer Res"},{"key":"941_CR21","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00262-009-0733-4","volume":"58","author":"M Reuschenbach","year":"2009","unstructured":"Reuschenbach M, von Knebel Doeberitz M, Wentzensen N (2009) A systematic review of humoral immune responses against tumor antigens. Cancer Immunol Immunother 58:1535\u20131544","journal-title":"Cancer Immunol Immunother"},{"key":"941_CR22","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1073\/pnas.94.5.1914","volume":"94","author":"YT Chen","year":"1997","unstructured":"Chen YT, Scanlan MJ, Sahin U, T\u00fcreci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94:1914\u20131918","journal-title":"Proc Natl Acad Sci USA"},{"key":"941_CR23","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-2362.2004.01311.x","volume":"34","author":"D Weber-Mzell","year":"2004","unstructured":"Weber-Mzell D, Kotanko P, Hauer AC, Goriup U, Haas J, Lanner N, Erwa W, Ahmaida IA, Haitchi-Petnehazy S, Stenzel M, Lanzer G, Deutsch J (2004) Gender, age and seasonal effects on IgA deficiency: a study of 7293 Caucasians. Eur J Clin Invest 34:224\u2013228","journal-title":"Eur J Clin Invest"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0941-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-012-0941-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-012-0941-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T23:51:33Z","timestamp":1559433093000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-012-0941-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,2]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["941"],"URL":"https:\/\/doi.org\/10.1007\/s12094-012-0941-9","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,2]]}}}